|
Medtronic received information that during the attempted implant of a 34 mm transcatheter bioprosthetic valve, the first deployment was deep and the valve appeared to migrate ventricular throughout the deployment despite narrowed left ventricular outflow tract and rapid pacing.On the initial deployment, a tab from the actuator came loose and was snapped back into place.Upon recapture of the valve up the 2nd-3rd node, the deployment knob broke and was unable to be assembled together.The device was able to be recaptured "enough" to safely remove from the patient.A 26 mm non-medtronic valve (edwards s3) valve was implanted with no issues.No adverse patient effects were reported.
|
|
This report is being submitted as part of remediation activities associated with capa 643143, addressing mdr reporting guidance from the fda¿s 1995 preamble, which ensures complaints related to corrections and recalls previously reported to the fda under 21 cfr 806 are now reported as mdrs; this is not a new malfunction/event.Product analysis: upon receipt of the suspect complaint delivery catheter system (dcs) at medtronic's quality laboratory, the dcs was received with the end cap/screw gear snap fit connected, the capsule was fully closed and slightly over captured.The actuator components were returned attached to the dcs, but the actuator components were not attached to the carriage components.Visual analysis showed handle was not intact.The tip-retrieval mechanism, inner member shaft, and spindle hub appeared intact with no evidence of damage.Delamination was observed over the nitinol reinforcing frame along the mid-section to the proximal end of the capsule.During functional testing, the trigger moved to fully advanced and retracted positions and locked in place when released.After the successful retraction of the capsule, the actuator components separated.A hairline crack was observed on tab 4 of the male actuator component.Tab 4 was detached from the male actuator component.Conclusion: the device history record was reviewed and showed this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Potential factors that can influence dislodgement include tension applied on the dcs during positioning, calcification levels and shape of the native anatomy.Dislodgement events do not typically indicate a device malfunction or a failure to meet manufacturing specifications.The cause of the reported dislodgement could not be conclusively determined.Delamination typically occurs when the capsule is subjected to a bending force potentially after tracking through patient anatomy.The device was received with the capsule slightly over-captured.The device instructions for use (ifu) cautions the user to ¿stop advancing the capsule once the gap to the catheter tip is closed.Advancing the capsule farther could damage the capsule¿.The device was received with the actuator components attached to the dcs, but the actuator components were not attached to the carriage components.After the successful retraction of the capsule, the actuator components separated.Actuator separation is typically associated with broken or damaged snap fit tabs, either one tab or both, which hold the handle together.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|